Abstract
Major histocompatibility complex (MHC) class I molecules can present antigenic peptides to CD8+ T cells, a process pivotal for anti-tumor and anti-viral immunity. Newly synthesized class I MHC is assembled in the ER and transported to the cell surface, only when stably complexed with high-affinity peptide. At the plasma membrane,
... read more